Amphastar Pharmaceuticals (AMPH) Gains from Investment Securities (2013 - 2026)

Amphastar Pharmaceuticals' Gains from Investment Securities history runs 14 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• In Q1 2026, Gains from Investment Securities rose 78050.5% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $6.2 million (up 281631.64% YoY), while the FY2025 annual figure was $6.9 million, up 3.44% from the prior year.
• Gains from Investment Securities was $1.7 million for Q1 2026 at Amphastar Pharmaceuticals, up from $434000.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $7.0 million in Q2 2024 to a low of $2206.0 in Q1 2025.
• Historically, Gains from Investment Securities has averaged $2.1 million across 5 years, with a median of $1.1 million in 2022.
• The sharpest annual moves came in 2024 and 2026: Gains from Investment Securities slumped 99.45% in 2024, then surged 78050.5% in 2026.
• A 5-year view of Gains from Investment Securities shows it stood at $1.1 million in 2022, then soared by 368.12% to $5.4 million in 2023, then slumped by 31.39% to $3.7 million in 2024, then sank by 88.23% to $434000.0 in 2025, then surged by 297.24% to $1.7 million in 2026.
• The last three Gains from Investment Securities figures came in at $1.7 million (Q1 2026), $434000.0 (Q4 2025), and $370000.0 (Q3 2025), per Business Quant data.